Skip to content
PubMed This is a summary of 11 peer-reviewed journal articles Updated
Gastroenterology

Standard of Care: From Clearance to Surveillance

At a Glance

The primary treatment for Serrated Polyposis Syndrome (SPS) is a rigorous schedule of colonoscopies to remove precancerous polyps. After an initial phase to clear polyps larger than 5mm, patients require lifelong surveillance colonoscopies every 1 to 2 years to prevent colorectal cancer.

The primary goal of managing Serrated Polyposis Syndrome (SPS) is to prevent colorectal cancer while preserving as much of your natural colon as possible [1][2]. For the vast majority of patients, this is achieved through a rigorous, proactive schedule of colonoscopies rather than surgery [3].

The Path to “Endoscopic Clearance”

When you are first diagnosed, you enter what is often called the clearing phase. During this time, your gastroenterologist’s mission is to achieve endoscopic clearance [3].

  • What is clearance? Clearance is defined as the successful removal of all visible polyps that are 5 mm or larger [3][4].
  • How long does it take? It may take more than one procedure to safely clear the colon, especially if there are many polyps or if some are in difficult-to-reach locations [3].
  • Why 5 mm? Research suggests that polyps smaller than 5 mm carry a very low immediate risk, so doctors focus their energy on the larger “clinically significant” lesions first [3][4].

The Surveillance Phase

Once your doctor has successfully cleared your colon, you move into the surveillance phase. The goal here is “maintenance”—catching and removing new polyps before they have a chance to grow large or become dangerous [5][6].

  • Standard Interval: Current guidelines typically recommend a surveillance colonoscopy every 1 to 2 years [3][7].
  • Lifelong Commitment: Because the risk of developing new polyps (metachronous lesions) persists throughout your life, these regular check-ups are generally recommended for the long term [8][5].
  • Consistency is Key: It is usually discouraged to extend the time between colonoscopies beyond two years, even if several previous check-ups were clear, because serrated polyps can grow and change relatively quickly [8].

Coping with Surveillance Fatigue

We recognize that going through a colonoscopy prep every 1 to 2 years is physically uncomfortable and emotionally exhausting. “Surveillance fatigue” is very real for patients with SPS. It helps to remember that the prep is the hardest part, and this demanding schedule is the exact reason why most patients survive and avoid surgery [1].

If your local gastroenterologist is not confident in finding flat serrated lesions, do not hesitate to ask for a referral to an advanced endoscopy center or a large research hospital where they see SPS frequently.

When is Surgery Considered?

Surgery—specifically a (sub)total colectomy (removing all or most of the colon)—is considered a last resort [1]. In modern care, most SPS patients will never need surgery [2]. However, your care team may discuss surgical options if:

  1. Uncontrollable Burden: The number of polyps is so high that they cannot all be safely removed during a colonoscopy [1][4].
  2. Inaccessible Locations: A high-risk polyp is located in a spot where it cannot be removed endoscopically [1].
  3. Invasive Cancer: If a biopsy shows that a polyp has already transformed into invasive cancer [9].
  4. High-Grade Dysplasia: If polyps with very advanced pre-cancerous changes (high-grade dysplasia) keep appearing and cannot be cleared [9][10].

By sticking to your 1–2 year schedule, you are actively modifying your risk profile [6]. When patients are managed by experienced gastroenterologists using high-definition equipment, the risk of developing cancer is drastically reduced [1][11].

Common questions in this guide

What is the clearing phase in SPS management?
The clearing phase is the initial treatment period after an SPS diagnosis. The goal is for your gastroenterologist to achieve endoscopic clearance by finding and removing all visible polyps that are 5 millimeters or larger.
How often do I need a colonoscopy for Serrated Polyposis Syndrome?
Current guidelines generally recommend having a surveillance colonoscopy every 1 to 2 years. It is highly discouraged to extend the time beyond two years, even after clear check-ups, because serrated polyps can grow and change quickly.
Will I need surgery to treat Serrated Polyposis Syndrome?
Most patients with SPS will never need surgery. Removing the colon, known as a colectomy, is considered a last resort and is only recommended if the polyp burden is uncontrollable, high-risk polyps cannot be reached, or invasive cancer is found.
What should I do if my doctor cannot safely remove all of my polyps?
If your local gastroenterologist is unable to safely manage a high number of polyps or struggles to find flat lesions, you should ask for a referral to an advanced endoscopy center. Specialists at these centers have more experience and specialized equipment for managing SPS.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Am I currently in the 'clearing' phase or the 'surveillance' phase of my care?
  2. 2.Are there any polyps larger than 5 mm that you were unable to remove during my last procedure?
  3. 3.Based on my current polyp burden, do you anticipate that we will be able to continue managing this endoscopically?
  4. 4.What specifically would happen in my case that would cause us to discuss surgery as an option?
  5. 5.Will you use chromoendoscopy during my next surveillance visit to ensure we don't miss any flat lesions?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (11)
  1. 1

    Feasibility and Safety of Endoscopic Control for Patients with Serrated Polyposis Syndrome.

    Nakaoka M, Chiba H, Kobayashi M, et al.

    Digestive diseases (Basel, Switzerland) 2024; (42(1)):31-40 doi:10.1159/000534968.

    PMID: 37967542
  2. 2

    Reducing the polyp burden in serrated polyposis by serial colonoscopy: the impact of nationally coordinated community surveillance.

    Parry S, Burt RW, Win AK, et al.

    The New Zealand medical journal 2017; (130(1451)):57-67.

    PMID: 28253245
  3. 3

    Optimal Endoscopic Treatment and Surveillance of Serrated Polyps.

    Gupta V, East JE

    Gut and liver 2020; (14(4)):423-429 doi:10.5009/gnl19202.

    PMID: 31581390
  4. 4

    Diagnosis, epidemiology and management of serrated polyposis syndrome: a comprehensive review of the literature.

    Fousekis FS, Mitselos IV, Christodoulou DK

    American journal of translational research 2021; (13(6)):5786-5795.

    PMID: 34306326
  5. 5

    Serrated Polyposis Syndrome with a Synchronous Colon Adenocarcinoma Treated by an Endoscopic Mucosal Resection.

    Lee SH, Lee SJ, Park SC, et al.

    The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi 2020; (76(3)):159-163 doi:10.4166/kjg.2020.76.3.159.

    PMID: 32969364
  6. 6

    Risk of Colorectal Cancer in Serrated Polyposis Syndrome: A Systematic Review and Meta-analysis.

    Muller C, Yamada A, Ikegami S, et al.

    Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2022; (20(3)):622-630.e7 doi:10.1016/j.cgh.2021.05.057.

    PMID: 34089849
  7. 7

    Germline variant testing in serrated polyposis syndrome.

    Murphy A, Solomons J, Risby P, et al.

    Journal of gastroenterology and hepatology 2022; (37(5)):861-869 doi:10.1111/jgh.15791.

    PMID: 35128723
  8. 8

    The long-term outcomes and natural disease course of serrated polyposis syndrome: over 10 years of prospective follow-up in a specialized center.

    Bleijenberg AGC, IJspeert JEG, Hazewinkel Y, et al.

    Gastrointestinal endoscopy 2020; (92(5)):1098-1107.e1 doi:10.1016/j.gie.2020.04.068.

    PMID: 32360902
  9. 9

    Low Incidence of Advanced Neoplasia in Serrated Polyposis Syndrome After (Sub)total Colectomy: Results of a 5-Year International Prospective Cohort Study.

    Bleijenberg AGC, IJspeert JEG, Carballal S, et al.

    The American journal of gastroenterology 2019; (114(9)):1512-1519 doi:10.14309/ajg.0000000000000339.

    PMID: 31403493
  10. 10

    Clinical risk factors of colorectal cancer in patients with serrated polyposis syndrome: a multicentre cohort analysis.

    IJspeert JE, Rana SA, Atkinson NS, et al.

    Gut 2017; (66(2)):278-284 doi:10.1136/gutjnl-2015-310630.

    PMID: 26603485
  11. 11

    Reasons why the diagnosis of serrated polyposis syndrome is missed.

    van Herwaarden YJ, Pape S, Vink-Börger E, et al.

    European journal of gastroenterology & hepatology 2019; (31(3)):340-344 doi:10.1097/MEG.0000000000001328.

    PMID: 30520764

This page provides educational information about Serrated Polyposis Syndrome management and surveillance guidelines. It does not replace professional medical advice from your gastroenterologist or care team.

Get notified when new evidence is published on Serrated polyposis syndrome.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.